LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 2 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 2. - Dataset (ID:20310)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 51.53 | 21.74 | 2916 | 5150 | 0.5661 | 0.8608 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.50 | 21.74 | 2626 | 5425 | 0.4840 | 0.8258 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.50 | 21.74 | 3147 | 5425 | 0.5800 | 0.8678 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.50 | 21.74 | 2368 | 5425 | 0.4364 | 0.8022 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.50 | 21.74 | 3230 | 5425 | 0.5953 | 0.8739 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.50 | 21.74 | 2969 | 5425 | 0.5472 | 0.8542 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 53.50 | 21.74 | 3091 | 5425 | 0.5697 | 0.8636 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.48 | 21.74 | 2863 | 5768 | 0.4963 | 0.8333 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.48 | 21.74 | 3385 | 5768 | 0.5868 | 0.8719 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.48 | 21.74 | 2997 | 5768 | 0.5195 | 0.8438 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.48 | 21.74 | 3440 | 5768 | 0.5963 | 0.8756 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.48 | 21.74 | 3103 | 5768 | 0.5379 | 0.8518 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 55.48 | 21.74 | 3280 | 5768 | 0.5686 | 0.8646 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.45 | 21.74 | 3119 | 6023 | 0.5178 | 0.8442 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.45 | 21.74 | 3587 | 6023 | 0.5955 | 0.8762 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.45 | 21.74 | 2841 | 6023 | 0.4717 | 0.8231 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.45 | 21.74 | 3645 | 6023 | 0.6051 | 0.8799 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.45 | 21.74 | 3322 | 6023 | 0.5515 | 0.8586 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 57.45 | 21.74 | 3460 | 6023 | 0.5744 | 0.8679 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 59.42 | 21.74 | 3276 | 6125 | 0.5348 | 0.8520 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 59.42 | 21.74 | 3832 | 6125 | 0.6256 | 0.8880 | MN20160310_N01 | G09 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 59.42 | 21.74 | 2801 | 6125 | 0.4573 | 0.8167 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 59.42 | 21.74 | 3861 | 6125 | 0.6303 | 0.8897 | MN20160310_N01 | H12 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 59.42 | 21.74 | 3538 | 6125 | 0.5776 | 0.8696 | MN20160310_N01 | L08 |
| MCF 10A-H2B-mCherry | Dasatinib | 0.31623 | 59.42 | 21.74 | 3677 | 6125 | 0.6003 | 0.8784 | MN20160310_N01 | L08 |